Clarity Pharmaceuticals - Radiopharmaceutical Therapies and Diagnostics

Clarity is a clinical stage company developing products to address the growing need for the use of radiopharmaceuticals in oncology.

SAR-bisPSMA - Next-Generation, Highly Targeted Prostate Cancer Theranostic - Clarity

Clarity's theranostic prostate cancer trial advances to cohort 2

News - Clarity Pharmaceuticals - Radiopharmaceutical Therapies and Imaging

Clarity Pharmaceuticals - Radiopharmaceutical Therapies and Diagnostics

Clarity Pharmaceuticals on LinkedIn: IND approval from the US FDA for theranostic SAR-Bombesin trial in…

Clarity Completes Site Activation for SARTATE™ Clinical Trial for the Treatment of Meningioma - Clarity Pharmaceuticals - Radiopharmaceutical Therapies and Imaging

First Participant Treated Using NorthStar Medical Radioisotopes' Electron Accelerator-produced Copper-67 (Cu-67) in Clarity Pharmaceuticals' Phase I/IIa Theranostic Clinical Trial Investigating Cu-67 SARTATE for Treatment of Neuroblastoma

Clarity Pharmaceuticals

Clarity Pharmaceuticals to Begin Phase 3 Trial for New PSMA PET Agent for Prostate Cancer

News - Clarity Pharmaceuticals - Radiopharmaceutical Therapies and Imaging